Cymabay Therapeutics Inc (CBAY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

7575 GATEWAY BOULEVARD NEWARK, CA 94560

Cymabay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases.

Data based on most recent fiscal year report
Market Cap133.965 Million Shares Outstanding68.7 Million Avg Volume1.572 Million
1-Yr BETA vs S&P TR0.816 Current Ratio12.59 Quick Ratio12.59
View SEC Filings from CBAY instead.

View recent insider trading info

Funds Holding CBAY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBAY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LOEWY CAROLINE M

  • Director
0 2020-03-13 0

BOUDES POL F CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-12 0

GOLDFISCHER CARL

  • Director
  • 10% Owner
0 2020-03-11 0

LANGE LOUIS G

  • Director
0 2020-01-15 0

TRUEX PAUL F

  • Director
0 2019-11-12 0

SHAH SUJAL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
120,000 2019-10-10 2

WILLS ROBERT JAMES

  • Director
0 2019-09-12 0

DORLING JANET CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-08-05 2

VAN WART HAROLD

  • Director
0 2019-06-27 0

PENHOET EDWARD

  • Director
0 2019-04-02 0

MCWHERTER CHARLES CHIEF SCIENCE OFFICER

  • Officer
0 2019-01-29 0

WEILAND ROBERT J.

  • Director
0 2019-01-29 0

STEIN EVAN A.

  • Director
0 2019-01-29 0

BOOTH ROBERT F.

  • Director
0 2019-01-29 0

MENOLD DANIEL VICE PRESIDENT, FINANCE

  • Officer
0 2019-01-29 0

DICKINSON KLARA CHIEF REGULATORY OFFICER

  • Officer
0 2019-01-29 0

EMSTER KURT VON

  • Director
0 2019-01-29 0

QUINLAN PAUL T GENERAL COUNSEL

  • Officer
0 2019-01-29 0

KUMAR HARI

  • Director
727,272 2019-01-02 0

MARTIN ROBERT L. SVP, NONCLINICAL & MANUF.

  • Officer
No longer subject to file 2018-01-24 0

OMARA PATRICK J. SVP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2018-01-24 0

VON EMSTER KURT

  • Director
0 2017-09-22 0

ROSEMARK KIRK V.P. REGULATORY & QUALITY

  • Officer
0 2017-01-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments